Wieczorek Maciej - Innovat Drugs R&D Dept, Celon Pharma SA

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 42 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

First-in-human study of CPL207280, a novel G-protein-coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration

Katarzyna Bazydlo-Guzenda,Katarzyna Jarus-Dziedzic,Agnieszka Gierczak-Pachulska,Pawel Buda,Piotr J. Rudzki,Katarzyna Bus-Kwasnik,Ewelina Juszczyk,Ewa Tratkiewicz, Daniel Rabczenko, Agnieszka Segiet-Swiecicka,Maciej Wieczorek

DIABETES OBESITY & METABOLISM（2024）

引用0浏览0引用

Abstract 3184: Development of an innovative bifunctional CPL976-MMAE conjugate based on a bispecific anti-PD-L1/ant-AXL antibody with a dual mechanism of action

Krysztof Lacek, Anna Jablonska, Olga Abramczyk, Martyna Janowska, Filip Mitula, Aleksandra Sowinska, Agnieszka Bojko-Matuszek, Tomasz Kornatowski, Damian Kolakowski, Magdalena Bojko,Monika Skupinska, Wiktor Pyra,

Cancer Researchno. 6_Supplement (2024): 3184-3184

引用0浏览0引用

Abstract 5084: A first-in-class bispecific antibody CPL976 with a dual PD-L1/AXL mechanism of action that promotes common biological antitumor effects in in vitro and in vivo models

Delfina Popiel, Damian Kołakowski, Agnieszka Bojko-Matuszek, Krzysztof Lacek, Anna Jabłońska, Aleksandra Sowińska,Filip Mituła, Magdalena Bojko, Bartosz Wiernicki, Agata Mikołajczyk, Tomasz Kornatowski, Krzysztof Flis,

Cancer Researchno. 6_Supplement (2024): 5084-5084

引用0浏览0引用

Simultaneous Detection of FGFR Gene Aberrations in Squamous Non-small Cell Lung Cancer Using Targeted DNA- and RNA-based NGS

J. Moes-Sosnowska, M. Skupinska, U. Lechowicz, P. Skronska, E. Szczepulska-Wojcik, A. Stepniewska, A. Rozy, R. Langfort, P. Rudzinski, T. Orlowski, D. Popiel,M. Wieczorek,

Journal of Thoracic Oncologyno. 9 (2022): S591-S592

引用0浏览0引用

Analysis Of Fibroblast Growth Factor Receptor 3 Aberrations In Bladder Cancer, For Enabling Personalized And Effective Therapy Based On Fgfr Inhibitor

R. Sosnowski, D. Popiel, P. Gapska, M. Skupinska, P. Stajno, M. Sobieszek-Prochorec, M. Ligaj, T. Demkow, A. Stanczak,M. Wieczorek, J. Pieczykolan

ANNALS OF ONCOLOGY（2021）

引用1浏览0引用

Rna-Based Gene Alteration And Expression Analysis In Sq-Nsclc With Known Fgfr1 Amplification And Protein Expression Status

J. Moes-Sosnowska,A. Rozy,M. Skupinska,U. Lechowicz,E. Szczepulska-Wojcik,R. Langfort,P. Rudzinski,T. Orlowski,D. Popiel,M. Wieczorek,A. Stanczak,J. Chorostowska-Wynimko

JOURNAL OF THORACIC ONCOLOGY（2021）

引用0浏览0引用

A Novel, Stable Mutation Of Fgf1 Separates The Glucose Lowering Effect From Its Proliferative Properties Through Interaction With The Insulin Receptor

M. Janiszewski, E. Drzazga, P. Buda, K. Bazydlo-Guzenda,B. Miedziak, A. Sowinska, O. Abramczyk, J. Hucz-Kalitowska, M. Teska-Kaminska,M. Wieczorek, J. Pieczykolan

DIABETOLOGIA（2021）

引用0浏览0引用

Safety And Pharmacokinetic Study Of Cpl207280, A Novel Gpr40 Receptor Agonist, After A Multiple-Dose In Healthy Volunteers